title: Reversible relapse of pemphigus foliaceus triggered by topical imiquimod suggests that Toll-like receptor 7 inhibitors may be useful treatments for pemphigus.
authors.forename: D F
authors.initials: DF
authors.lastname: Sebaratnam
authors.forename: L K
authors.initials: LK
authors.lastname: Martin
authors.forename: A I
authors.initials: AI
authors.lastname: Rubin
authors.forename: K
authors.initials: K
authors.lastname: Tran
authors.forename: H H
authors.initials: HH
authors.lastname: Pas
authors.forename: P J
authors.initials: PJ
authors.lastname: Marr
authors.forename: J
authors.initials: J
authors.lastname: Edmonds
authors.forename: D F
authors.initials: DF
authors.lastname: Murrell
mesh_terms: D000276:Adjuvants, Immunologic / Q000009:adverse effects*; D000287:Administration, Topical; D000634:Aminoquinolines / Q000009:adverse effects*; D002280:Basal Cell Carcinoma / Q000188:drug therapy / Q000473:pathology; D005260:Female; D006801:Humans; D000077271:Imiquimod; D008875:Middle Aged; D010392:Pemphigus / Q000139:chemically induced* / Q000188:drug therapy; D012878:Skin Neoplasms / Q000188:drug therapy / Q000473:pathology; D051199:Toll-Like Receptor 7 / Q000037:antagonists & inhibitors*; D016896:Treatment Outcome
chemical_list: D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D051199:Toll-Like Receptor 7; D000077271:Imiquimod